Pegasus Biotech Incorporated
$514,123.00 CAD
≈ 7 Canadians' average pay for a year
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2025-2026
- Agreement period
- April 1, 2025 – March 30, 2027
- Reference
- nrc-cnrc:172-2025-2026-Q1-1028954
Published purpose
This project leverages the combined vaccine development platform technologies of Pegasus Biotech, ConserV Bio and 4BaseBio to evaluate and enhance the manufacturing capability of a novel Canadian plasmid DNA technology platform (BPE) in the production of a new class of human influenza vaccines based on ConserV Bio's FLU-v technology.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions